We are live on ! Find out more
QNCX icon

Quince Therapeutics
QNCX

40 hedge funds and large institutions have $8.4M invested in Quince Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

5% more funds holding

Funds holding: 38 → 40 (+2)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 0.12% → 0.1% (-0.02%)

38% less capital invested

Capital invested by funds: $13.5M → $8.4M (-$5.11M)

Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
8
Closed
2
Calls
$87K
Puts
–
Net Calls
+$87K
Net Calls Change
-$78K

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$109K
2
Jane Street
Jane Street
New York
+$99K
3
Mariner
Mariner
Kansas
+$98K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$74.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$47.3K

Top Sellers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
-$2.12M
2
KAM
Knightsbridge Asset Management
California
-$344K
3
TCM
Tang Capital Management
California
-$149K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$77.3K
5
Two Sigma Investments
Two Sigma Investments
New York
-$65.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$10.7K +$3.13K +12 +33%
UBS Group
27
UBS Group
Switzerland
$7.47K +$7.32K +28 +560%
Citigroup
28
Citigroup
New York
$5.79K – – –
PA
29
Parallel Advisors
California
$2.66K – – –
Wells Fargo
30
Wells Fargo
California
$1.36K +$1.31K +5 +500%
JP Morgan Chase
31
JP Morgan Chase
New York
$525 – – –
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$441 – – –
JFG
33
JDM Financial Group
Texas
$381 – – –
FP
34
Financial Perspectives
Minnesota
$347 – – –
Osaic Holdings
35
Osaic Holdings
Arizona
$310 – – –
AF
36
Allworth Financial
California
$300 – – –
Barclays
37
Barclays
United Kingdom
$224 – – –
FA
38
Financial Avengers
California
$112 – – –
HGERS
39
Householder Group Estate & Retirement Specialist
Arizona
$112 +$261 +1 New
WIM
40
Westside Investment Management
California
$84 – – –
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$66 – – –
BCM
42
BML Capital Management
Indiana
– -$2.12M -7,059 Closed
KAM
43
Knightsbridge Asset Management
California
– -$344K -1,143 Closed
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
– -$261 -1 -50%
1
2

QNCX Hedge Fund Activity: Q3 2023 in Review

40 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Quince Therapeutics (QNCX) for Q3 2023, worth a combined $8.4M — down 38% from $13.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new QNCX positions and 2 closed out — a net gain of 2 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Bridgeway Capital Management, adding an estimated $109K. The largest seller was BML Capital Management, exiting entirely with an estimated $2.12M sold.

  • 40 institutional investors held Quince Therapeutics (QNCX) as of Q3 2023, up from 38 in Q2 2023.
  • Funds reported $8.4M of Quince Therapeutics stock for Q3 2023, down 38% quarter-over-quarter.
  • 4 funds opened new Quince Therapeutics positions in Q3 2023 and 2 closed out, a net change of +2 holders.
  • The largest Quince Therapeutics buyer in Q3 2023 was Bridgeway Capital Management, an estimated $109K added.
  • The largest Quince Therapeutics seller in Q3 2023 was BML Capital Management, an estimated $2.12M sold.

Based on aggregated 13F filings for Q3 2023.